Dasotraline SEP360-105 Pediatric PK/PD Study
Public ClinicalTrials.gov record NCT02195167. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Pediatric PK study of SEP-225289 (Dasotraline)
Study identification
- NCT ID
- NCT02195167
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 105 participants
Conditions and interventions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2014 (Type not available)
- Primary completion
- Mar 2015 (Actual)
- Completion
- Mar 2015 (Actual)
- Last update posted
- Mar 31, 2015
2014 – 2015
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Woodland International Research Group | Little Rock | Arkansas | 72211 | — |
| MCB Clinical Research Centers, LLC | Colorado Springs | Colorado | 80910 | — |
| Palm Springs Research Institute | Hialeah | Florida | 33012 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30308 | — |
| iResearch Atlanta, LLC | Decatur | Georgia | 30030 | — |
| Louisiana Research Associates, Inc | New Orleans | Louisiana | 70114 | — |
| Wake Research | Raleigh | North Carolina | 27612 | — |
| IPS Research Company | Oklahoma City | Oklahoma | 73103 | — |
| Cutting Edge Research Group | Oklahoma City | Oklahoma | 73116 | — |
| Clinical Trials of Texas, Inc. (CTT) | San Antonio | Texas | 78229 | — |
| Road Runner Research | San Antonio | Texas | 78258 | — |
| Aspen Clinical Research | Orem | Utah | 84058 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02195167, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2015 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02195167 live on ClinicalTrials.gov.